surmount studies tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide as Compared with Semaglutide

Results show broad benefits with a reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions

A recent composition for the Obesity Medicine Association titled "A New Path Forward" highlights struggles people living with obesity face, and has been viewed over 4,000 times

Fox Foundation to present an

Too often associated with Hollywood starlets, GLP-1 medication has changed the lives of those facing diabetes, liver disease and heart disease.

Weight Loss Can Be Incredibly Difficult

Visit Gameday Mens Health in Diamond Bar, CA for expert testosterone therapy, ED treatment, weight loss support, and vitamin injections